retatrutide fat loss clinical trial New Phase 3 data just dropped 👀 Eli Lilly's reported average weight approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide vs Ozempic: Clinical Trial

An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria

Justification for use of FL83B mouse hepatocytes and mouse C2C12 myoblasts Liver is a major player in the synthesis and secretion of VDBP and the hydroxylation of cholecalciferol (vitamin D 3 ) to 25-hydroxy-vitamin D

instead of being a single GLP-1 receptor agonist like semaglutide, tirzepatide is a GLP-1/glucose insulinotropic peptide (GIP) dual agonist, which explains the greater weight loss it delivers

Genomic Stratification for Precision Therapy Next-generation sequencing has enabled molecular subtyping of MPNSTs, identifying actionable mutations such as CDKN2A/B deletions, PRC2 inactivation, and TP53 mutations

Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry